Expression and characterization of FAT1 and atrophin 1 proteins regulating planar cell polarity and MBD1 protein involved in lymphoma by ANUPAMA VAASUDEVAN
EXPRESSION AND CHARACTERIZATION OF 
FAT1AND ATROPHIN 1 PROTEINS REGULATING PLANAR 























A THESIS SUBMITTED FOR 










DEPARTMENT OF BIOLOGICAL SCIENCES 
 
NATIONAL UNIVERSITY OF SINGAPORE 
2008 
EXPRESSION AND CHARACTERIZATION OF 
FAT1AND ATROPHIN 1 PROTEINS REGULATING PLANAR 























A THESIS SUBMITTED 
FOR 
THE DEGREE OF MASTER OF SCIENCE 
DEPARTMENT OF BIOLOGICAL SCIENCES 
NATIONAL UNIVERSITY OF SINGAPORE 
2008 
iACKNOWLEDGEMENT
In the words of Ludwig Wittgenstein “Knowledge is in the end based on 
acknowledgment.” The entire process of my knowledge acquisition would be incomplete 
without due recognition of each and every contributing member.
I would start by thanking my P.I. Dr. K Swaminathan. To me, as a novice at 
research, he provided me with flexibility. He was extremely encouraging and patient at 
all times and helped me learn things very clearly. His excellent teaching of the basics of 
crystallography has helped me understand a tiny spec of this vast interesting topic and 
appreciate the need to solve structures to understand the working of complex protein 
pathways. The two projects that I worked on were not only of high biological 
significance, but also empowered me with the ability to think, plan  independently, which 
is the hallmark of a true researcher. I would thus wholeheartedly like to thank him for this 
enriching experience that I experienced as a part of his lab.
I would proceed to thank the two collaborators, Professors Sarah Miller and 
Mariusz Wasik from the University of Pennsylvania for providing me with the initial 
mRNA, to start my project.
All my labmates have played a vital role in my journey as a graduate student. No 
words suffice to thank them for providing such a pleasant environment throughout: 
Vindhya for being my friend and confident always while Shiva and Kuntal deserve a 
special word of thanks. Starting out together, I remember all the times we troubleshooted 
and brainstormed solutions for each other, the great camaraderie we shared and 
ii
enjoyment both at lab and outside it. I thank Pankaj for his help, especially during my 
pre-thesis defense and Toan for his cheerful spirit, for enlivening  me  at all times.  
A note of thanks to all members of Lab 5 for always being responsive to any 
technical doubt I have had. I thank Karthik for teaching the basics of CD and helping me 
with valuable suggestions at all time. I owe big thanks to my friends Sunita, Sujatha, 
Nilofer, Ambalika, Gayathri, Suguna, Kripa, Suketa, Rashmi and all the others both at 
NUS and outside for playing a very sweet and special role in making my stay in 
Singapore extremely enjoyable and pleasant.
A huge thanks to my cousin Mahalakshmi and her family, for providing me a 
home away from home, for always being there for me and being the lovable elder sister I 
always wanted.
Finally I would like to dedicate this thesis to my parents and thank them, for being 
my support system and backbone, through good and trying times and for the





Table of contents ii
Summary ix
List of Abbreviations xi
List of Figures xiii
List of Tables xvi
 CHAPTER 1    MACROMOLECULAR X-RAY CRYSTALLOGRAPHY
1.1 Protein Structure Determination 1
1.2 Protein crystallography 1
1.2.1 X-ray crystallography of proteins 2
1.3 Basic Concepts in Crystallography 2
1.3.1 Unit-cell and lattices 2
1.3.2 Symmetry, point groups and space groups 3
1.3.3 Crystals and X-rays 4
1.3.4 X-Ray Diffraction 5
1.3.5 Bragg’s Law 5
1.3.6 Reciprocal Lattice and Ewald sphere 6
   1.3.5.1   Ewald sphere          6
iv
1.3.7 Fourier transform, structure factor and phase Problem 7
1.4 Geometric Data Collection 7
1.5 Structure Determination 9
1.5.1 Phasing Techniques 9
    1.5.1.1   Direct method 9
   1.5.1.2    Molecular replacement 9
  1.5.1.3    Multiwavelengh isomorphous replacement 9
  1.5.1.4   Anomalous Dispersion 10
1.5.2 Model building and refinement 10
  1.5.2.1   R Factor 11
1.5.3 Validation and presentation 11
 1.5.3.1    Ramachandran Plot 11
 1.5.3.2    Folding profile methods 12
CHAPTER 2    BIOLOGICAL BACKGROUND
2.1 Cell Signaling 13
2.2 WNT Signaling Pathway 13
2.2.1 Classification of Wnt pathways 14
2.3 Planar Cell Polarity (PCP) 16
2.3.1 Biological significance 16
2.4 Fat 1 17
v2.4.1 Architecture of Fat1 18
   2.5 ATROPHIN 1   19
2.5.1 Architecture of Atrophin 1 20
2.6 Role of Fat and Atrophin1 in PCP 21
2.6.1 Domains of interest 23
2.7 DNA Methylation 24
2.7.1 Components of DNA methylation 25
2.8 Methyl Binding Domain Protein 1 25
2.8.1 Domain architecture of MBD1 26
2.8.2 Biological significance of MBD1 27
2.9 OBJECTIVE 27
CHAPTER 3    MATERIALS AND METHODS
3.1 Cloning Of C-Terminal Fat1 and Atrophin1 30
3.1.1 Cloning of C-terminal Fat1 30
3.1.2 Cloning of C-terminal Atrophin1 31
3.1.3 Blue white colony screening 32
3.2 Subcloning Of Fat1 and Atrophin1 33
3.2.1 Touch up PCR for Fat1 and Atrophin1 33
3.2.2 Double digestion, phenol-chloroform purification and ligation of Fat1 33
3.2.3 Digestion, Phenol Chloroform extraction and Ligation of Atrophin1 35
3.3 PROTEIN Expression And PurificatiON 35
3.3.1 Expression of Fat1 35
vi
3.3.2 Purification of Fat1 36
   3.3.2.1   Affinity Purification 36
  3.3.2.2    Size exclusion chromatography 36
3.3.3 Dynamic Light Scattering 37
3.3.4 Crystallization 37
3.4 Expression and Purification of Atrophin1 37
3.4.1 Expression analysis of Atrophin1 cloned in pQE30 37
  3.4.2.1    Affinity purification and refolding 38
 3.4.2.2    Slow dilution and reverse phase HPLC 38
 3.4.2.3    Circular dichrorism 39
3.4.2 Expression and Purification of Atrophin1 cloned in pET32A 39
 3.4.2.1    Expression 39
 3.4.2.2   Affinity purification 39
 3.423.3  Size exclusion chromatography 40
3.4.3 Thioredoxin tag cleavage 40
3.4.4 Dynamic Light Scattering 40
3.4.5 Crystallization set up 41
3.5 Cloning and Expression of MBD1 41
3.5.1 Cloning of MBD1 41
3.5.2 Expression of MBD1 42
CHAPTER 4    RESULTS AND DISCUSSION
                                        
vii
4.1 Cloning of Fat1 and Atrophin1 43
4.2 Expression of Fat1 and Atrophin1 47
4.2.1 Expression of Fat1 47
4.2.2 Expression of Atrophin1 48
   4.2.2.1   Final Expression 48
4.3 Purification of Fat1 50
4.3.1 Affinity purification and Size exclusion Chromatography 50
4.3.2. Dynamic light scattering 52
4.3.3 Maldi-TOF and peptide mass finger printing 54
4.4 Purification of Atrophin1 55
4.4.1 Refolding of Atrophin 1 55
    4.4.1.1   Denaturation ,Refolding and Purification 55
   4.4.1.2  Circular Dichrorism 57
4.4.2 Final Expression using pET32 construct 58
   4.4.2.1 Affinity purification and size exclusion chromatography 58
4.4.3 Dynamic Light Scattering and Thioredoxin Tag Cleavage 60
4.4.4 Peptide mass finger printing 61
4.5 Cloning Methyl Binding Domain Protein 1 62
4.5.1 Subcloning of MBD1 62
4.5.2 MBD1 expression 62
                                                                                                                                 
CHAPTER 5    CONCLUSION AND FUTURE STUDIES
viii
5.1 Conclusion 65
5.2 Future directions 67
5.2.1 Fat1 and Atrophin1 67
5.2.2 MBD1 68
REFERENCES
APPENDIX         
ix
SUMMARY
Fat, the first tumor suppressor gene to be discovered in Drosophilla melanogester, 
is one of the most important regulators of planar cell polarity which controls the 
directional alignment of hair bristles and photoreceptors in the eyes of Drosophilla. The 
mammalian counterpart of Fat known as Fat1 has been found to play a vital role during 
cerebral development, glomerular slit formation and gastrulation. Atrophin1 (also known 
as grunge) is a nuclear receptor which is predominately found in the nucleus but 
sometimes shuttles to the cytoplasm. The C-terminus of Atrophin is shown to interact 
with the C-terminal domain of Fat in the regulation of planar cell polarity. The precise 
role of these two important molecules in planar cell polarity is yet to be fully understood. 
Apart from its role in the Fat-Atrophin complex, Atrophin1 like proteins have been 
implicated in Dentatorbral Pallidoluysian Atrophy, is a dominantly inherited neuronal 
degenerative disease characterized by the variable combination of ataxia epilepsy and 
dementia. The disease is caused by the expansion of a polyglutamine tract with a 
Atrophin1 protein. The structures of the C-terminal domains of Fat1 (160 a.a.) and 
Atrophin1 (196 a.a.) from Mus musculus (to be solved, separately and for their complex, 
using X-ray crystallography) will provide a pedestal for understanding the roles of Fat1 
and Atrophin1 in the mechanism of regulation in planar cell polarity. 
MBD1 or Methyl binding domain 1 protein belongs to the class of Methyl CpG 
binding proteins (MBD 1-4 and MeCP2).The sequence similarity of these proteins is 
xrestricted only in their MBD domain, thus highlighting different roles. MBD1 has 
additional TRD and Zinc finger domains, which bind to non-methylated DNA and silence 
them, while the MBD domain silences hypermethylated DNA. The dual DNA binding 
capacity of MBD1 is of great importance in understanding tumorigenesis, very little of 
which is currently known. The solution structure of the human MBD domain in complex 
with DNA has been solved. Currently, we are cloning full length MBD1 (605 a.a.) from a 
human lymphoma cell line into the p Fast Bac Htb vector for baculovirus expression.





CCD Charged coupled device
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IPTG  Isopropyl β-D-1-thiogalactopyranoside
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MACROMOLECULAR X-RAY CRYSTALLOGRAPHY 
 
1.1 PROTEIN STRUCTURE DETERMINATION 
 
The causative agents of most diseases like cancer and Alzheimer’s are 
proteins. As basic cell constituents and regulatory players, proteins are indispensable 
part of the human body and its functions. The function of a protein can be fully 
appreciated only when we have a complete knowledge of its 3-dimensional structure, 
as structure and function go hand in hand to provide a complete picture.  
Currently, Nuclear Magnetic Resonance (NMR) and X-ray crystallography are 
two of the most popular methods used for protein structure determination at atomic 
details. X-ray crystallography has an advantage over NMR, which poses a restriction 
on protein size that can be solved. Even though around 35,000 protein structures have 
been solved, this number is only a small fraction of the thousands of proteins whose 
structures are waiting to be determined. 
 
1.2 PROTEIN CRYSTALLOGRAPHY 
 
Crystallography is the study of atomic arrangements in crystals and minerals. 
With the help of X-ray diffraction, it has been used as a method to determine the 
structure (or atomic distribution) of several molecules. Crystallization is one of the 
several means (including nonspecific aggregation/precipitation) by which a 
metastable supersaturated solution can reach a stable lower energy state by reduction 
of solute concentration (Weber, 1991). The three stages of crystallization that are 
common to all molecules are nucleation, growth, and cessation of growth.  
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1.2.1 X-ray crystallography of proteins 
 
Earlier studies of crystallography were primarily based on the geometry of 
crystals. After 1912, structure determination depends on the study of diffraction 
patterns produced when a crystalline sample is irradiated by X-rays (and neutrons in 
some cases). The diffraction pattern obtained in X-ray crystallography is due to the 
scattering of X-rays by the electron in the sample. However, the protein of interest has 
to be crystallized first (Fig. 1.1) because of the ordered arrangement of atoms, 






Figure 1.1. A Protein Crystal 
 
1.3 BASIC CONCEPTS IN CRYSTALLOGRAPHY 
1.3.1 Unit-cell and lattices 
 A crystal consists of a large number of molecules, which are arranged in a 
particular manner. A regular pattern of arrangement of an array of points periodically 
in three dimensional spaces is known as a lattice. In a crystal, a unique volume of 
space, which is repeated in three dimensions, is called a unit-cell. If each box is 
represented by a point, then the arrangement of all unit-cells will form a lattice. Even 
though every crystal has a reduced unit–cell (minimum volume), in some crystals we 
select a bigger unit-cell (that would include smaller unit-cells), which would satisfy 
the full symmetrical needs of the crystal. The least volume unit-cell, which is the 
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natural unit-cell in several crystals, is called the primitive unit-cell and the bigger 
unit-cell in some selected cases is called a centered unit-cell.  
The geometry of a unit-cell is defined by three non-coplanar axes (a, b, c) and 
their inter-axial angles (α, β, γ). A crystal system is named after the symmetrical 
requirements of that system and it adopts the corresponding unit-cell. The seven 
systems are triclinic, monoclinic, orthorhombic, tetragonal, trigonal, hexagonal, and 
cubic. While all other systems use the corresponding unit-cell, the trigonal system 
uses either a hexagonal unit-cell or a rhombohedral unit-cell, depending on the 
symmetry of that particular crystal. These seven systems, depending on the use of the 
corresponding unit-cell, produce 14 Bravais lattices (Fig. 1.2). 
  
1.3.2 Symmetry, point groups and space groups 
 
Symmetry in a crystal can be defined as the arrangement of atoms occupying 
minimum volume, identical and repeats itself throughout the crystal. There are three 
types of symmetry operations in crystallography, rotation, reflection and inversion. 
The rotational symmetry needs an axis to act upon and produces identical images of 
an object, around the axis. The number of images generated in crystallography by the 
rotational symmetry can be 1, 2, 3, 4 or 6. The reflection symmetry acts upon a plane 
and inversion occurs through a point. The 32 point groups in crystallography 
describe the unique combinations of these symmetry elements (without any 
translational component applied to them) in all unit-cell. When a translational 
component is applied to the symmetry operations rotation and reflection, two 
additional types of symmetry, the screw axis and the glide plane, are generated. The 
complete description of a crystal, including the crystal system, lattice type and 
symmetry elements, is known as the space group of that crystal. There are 230 space 
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groups in crystallography and proteins crystallize only in 65 space groups (without 














Figure 1.2. The Bravais lattices (figure adopted from www.infosteel.net) 
 
1.3.3 Crystals and X-rays  
 
Visible light has the advantage of being focused by a lens and thus it can 
produce an enlarged image of an object. X-rays, on the other hand cannot be focused. 
However, the electrons in a crystal diffract X-rays and virtually we look at the 
structure of electron distribution. The objective in X-ray crystallography is to grow 
crystals to an optimum size and quality for study by diffraction. Crystals are generally 
grown to 0.1-0.3mm by using different techniques. In case of small molecules, 
crystals are easier to form than proteins. This is due to the complexity of protein 
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molecules and their low availability. Protein crystals are grown by several techniques, 
including the most common vapor diffusion (hanging drop and sitting drop method) 
and batch methods. 
 
1.3.4 X-Ray Diffraction 
 
X-ray diffraction is best explained if the radiation is taken as a wave, Eq. 1.1.   
     E=Asinωt     (Eq. 1.1) 
Where A is the amplitude, ω is circular velocity, t is time and E is the energy of the 
wave. X-rays interact with matter and get scattered in all directions. These scattered 
rays travel different length as they originate from different places in a crystal. They 
differ from one another with respect to their phase and amplitude. Two waves interact 
constructively when they are in phase (their amplitudes are magnified as the sum of 
the two waves) while the resultant wave decreases in amplitude if the waves are out of 
phase (Fig. 1.3). 
a            b 
 
Figure 1.3. Interference of two waves (a) constructively and (b) destructively. 
 
1.3.5 Bragg’s law 
 
 In crystals, atoms diffract X-rays. Each reflection is the combined effect of 
waves diffracted by all atoms in the crystal, governed by a set of parallel and equally 
spaced planes that slice all unit-cells in that particular orientation. According to 
Bragg’s law when X-rays with a wavelength λ are incident on a set of planes with 
Miller indices hkl (where h, k, l are the integral divisions of the unit-cell axes a, b, c, 
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respectively) and interplanar spacing of dhkl at an angle θ, they will produce a 
diffracted beam only if θ meets the following condition, Eq.1.2. 
     2 dhkl sinθ = nλ   (Eq. 1.2) 
where n is an integer (Rhodes, 2000). 
 
1.3.6 Reciprocal lattice and Ewald sphere 
 
A set of parallel planes with Miller indices hkl in real space is related to a 
point (hkl) in the reciprocal space. The direction of the reciprocal vector corresponds 
to the plane normal and the magnitude of the reciprocal vector is equal to the 
reciprocal of the interplanar spacing of the real space planes. 
 
1.3.6.1 Ewald sphere 
 
Bragg’s law can be rearranged in the reciprocal space using Eq. 1.4. 
Sinθ = λ/2dhkl   = (1/dhkl) / (2/λ)  (Eq. 1.4) 
The aim of the Ewald sphere is to determine which set of real space planes 
(represented by the grid points on the reciprocal space) will result in a diffracted 








Figure 1.4. Reciprocal space lattice and the Ewald sphere 
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1.3.7 Fourier transform, structure factor and phase problem 
 
The diffraction pattern of atoms in a crystal is related to the atomic 
arrangement through their Fourier transforms. Thus the electron density at any point 
in the unit-cell can be calculated by Eq. 1.5  
                 ρ (x, y, z) =1/V ∑∑∑ Fhkl e-2πi (hx+ky+lz)                (Eq. 1.5) 
Through this equation, we transform the diffraction effect in inverse space to real 
space electron density at every point x, y, z. In the above equation, if the structure 
factor Fhkl is known, we can calculate the atomic positions and thus the real structure. 
However, in crystallography to calculate the structure factor Fhkl, we need to know the 
atomic positions. The reverse Fourier transform of the structure factor equation, will 
give back the atomic position which is our ultimate aim, i.e. to ascertain the location 
of every atom in the structure from their diffraction pattern. This statement sounds 
illogical. In order to calculate the position of an atom in a structure we need to know 
two parameters about a diffracted wave: amplitude and the phase. While the 
amplitude is calculated from the intensity of a reflection, the phase of the wave, which 
depends on the positions of all atoms with respect to the origin of the unit-cell, is not 
measurable. This non-availability of phases is called the ‘phase problem’ in X- ray 
crystallography.  
 
1.4 GEOMERICAL DATA COLLECTION 
For crystal structure determination, the intensities most of, if not all, the 
diffracted beams must be measured. All corresponding reciprocal points must be 
bought to diffracting positions by rotating the crystal. First, the geometry of 
diffraction which includes the shape, size and symmetry information, is confirmed. 
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This is followed by the measurement of intensities which is ultimately related to the 













Figure 1.5. The anatomy of an X-ray diffractometer 
 
The X-ray diffractometer, Fig. 1.5, consists two parts, the mechanical part to rotate 
the crystal and the detector to measure the intensities of diffracted beams. There are 
three independent axes (ω, χ and φ) through which a crystal can be rotated to bring a 
desired set of planes into a diffracting orientation. Different physical devices, like 




1.5 STRUCTURE DETERMINATION 
1.5.1 Phasing techniques 
Four techniques are commonly used to derive phase information for structure 
determination. These methods provide a rough estimate of phases initially which is 
further improved using repetitive model building and refinement. 
 
1.5.1.1 Direct method 
 
This method can be used to solve structures containing 100 or less amino 
acids. It is based on the assumption that the structure is made of similarly shaped 
atoms and all the reflection produce positive electron density, and that there is a 
statistical relationship between sets of structural factors. The other requirement in case 
of direct method is the requirement for a very high resolution of data, at the order of 
1.2 Å or better. 
 
1.5.1.2 Molecular replacement 
 
This method is generally preferred to solve the phase problem when a good 
model for a reasonably large fraction of the structure exists. This just means that the 
sequence similarity must be at least 40% with the model being fairly complete. This 
method is very useful when the structures of structurally homologous proteins are to 
be solved. 
 
1.5.1.3 Multiwavelengh isomorphous replacement 
 
Developed in the early 1940s this method makes use of heavy atoms like gold, 
mercury or platinum. Initial diffraction pattern of a native crystal is collected, 
followed by soaking the crystal in two or more heavy atom solutions separately and 
collection of additional data sets. These heavy atoms contain more electrons than 
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normal protein atoms and hence they produce higher significantly varying intensity 
for every corresponding reflection. Therefore besides serving as spot markers, the 
change in spot intensities of these atoms help calculate initial phases which are further 
refined over successive refinement cycles. The reason for use of more than one heavy 
atom is in the fact that different metals bind to different regions in the protein, thereby 
aiding very much to resolve phase ambiguity.  
 
1.5.1.4 Anomalous Dispersion 
 
This method degenerates into single wavelength anomalous dispersion (SAD) 
or multi wavelength anomalous dispersion (MAD), with the latter being the common 
method used to study protein structures. When X-rays are incident on molecules 
heavier than carbon, nitrogen or oxygen part of the energy is absorbed and re-emitted 
at the same wavelength but at a different phase. This scattering is called ‘anomalous’ 
scattering. Certain atoms produce substantial anomalous scattering when compared to 
others in the useful wavelength range. The most common atoms utilized in X-ray 
crystallography are sulphur for SAD or selenium which replaces the sulphur in the 
methionine of a protein in MAD. The advantage of this method lies in the requirement 
for only one single good quality and well diffracting seleno-methionine crystal. 
 
1.5.2 Model building and refinement  
 
After scaling and indexing a data set using a program like HKL2000 and 
solving the phase problem by one of the above methods, an initial rough model of the 
structure is built. There are several model building programs like O or Coot. Once the 
initial model is built, the structure is further refined such that the atomic data is best 
fitted. Large numbers of systematic and random errors have an effect on the accuracy 
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of the initial model. Refinement is the process of adjusting the model to find a closer 
agreement between the calculated and observed structure factors by least-squares 
methods or molecular dynamics. This refinement is carried out several times until an 
accurate model of the structure is obtained. 
 
1.5.2.1 R Factor 
 
R-Factor or residual factor is the measure of agreement between the model and 
actual X-ray data. R factor is given by Eq. 1.6. 
 
     (Eq. 1.6) 
where Fobs is the measured structure facture and Fcalc is the structure factor obtained 
from the model. Usually, the R factor ranges between 0.2 - 0.25 for a good structure.  
 
1.5.3 Validation and presentation 
 
The structure is refined several times until a sufficiently low and acceptable R 
factor without affecting other parameters is achieved. The final structure requires 
validation before it can be presented. There are two important parameters that must be 
verified. 
 
1.5.3.1 Ramachandran Plot 
 
This powerful validation parameter is not used during the refinement process, 
but is used to check for the stereochemistry of a structure. For good validation, 
residue in the disallowed region should be further refined to get at least ninety 
percentage of the residues in the allowed region.  
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1.5.3.2 Folding profile methods 
 
Potential protein fold is assigned by searching databases for proteins with 
similar fold. Often proteins with similar sequence identity tend to show a similar fold. 
This method was established by Eisenberg and co-workers. 
The refined coordinates (positions of the atoms) are orthogonalized (arranged 
with respect to three orthogonal axes), even if the unit cell has non-orthogonal axes. 
The temperature factor is a good indicator about the thermal vibration of an atom. The 






















For my Masters, I carried out initial cloning and expression of three proteins. 
Fat1 and Atrophin1 belong to the Wnt signaling pathway and MBD1 has been 
explored for its role in gene regulation, especially in lymphoma. 
 
2.1 CELL SIGNALING 
 
Cell signaling governs the activities of a cell and its response to its immediate 
environment. Interaction with its microenvironment, and sometimes macro 
environment, in turn regulates development, immune responses and maintenance of 
homeostasis (Witzany, 2000). Any aberration in signaling in one or many molecule 
affects the entire pathway, leading to a plethora of diseases which range from 
developmental disorders to cancer of various types. At the molecular level, most of 
the cancers are caused due to dysfunction, up or down regulation of a signaling 
pathway, which in turn give the cells proliferative capacity.  
 
2.2 WNT SIGNALING PATHWAY 
 
Wnt signaling involves one group of signaling proteins that are best known for 
their role in normal physiological processes, like development of an adult animal. 
Recently, the Wnt pathway became a subject of tremendous interest, especially due to 
its proposed role in embryogenesis and cancer (Lie, 2005). The pathway derives its 
name as a combination of two genes. The first part is from the Drosophila 
melanogester Wg (wingless) gene that is involved in segment polarity during 
embryogenesis and the other being INT (integration), found at several sites of 
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integration in mouse mammary tumor virus (Nusse, 1991). The Wnt pathway 
involves a complex interplay of a large network of glycoproteins, which regulate a 
range of developmental process from simple organisms, like metazoan hydra to 
vertebrates. The generation of signaling molecules (Wnt ligands) and their interaction 
with corresponding receptors are controlled in this pathway. 
 
2.2.1 Classification of Wnt pathways 
 
Historically, the Wnt pathway has been broadly classified into canonical and 
non-canonical pathway. The difference highlights the functional specialization they 
have evolved for. While the canonical pathway was thought to be  involved in cell 
differentiation and carcinogenesis, body axis specification and morphogenetic 
signaling, the non-canonical pathway controls planar cell polarity, e.g., the direction 
of alignment of cells in the whole tissue such as the direction of hair in the skin 
(Fanto, 2004). The other significant difference between the two pathways is in the 
intermediate disheveled protein and β-catenin. In the canonical pathway (Fig. 2.1 a) 
the Wnt signal is stabilized by the presence of ß-catenin, which in turn enters the 
nucleus and controls the TCF/LEF family of transcription factors and specific cell 
signaling. On the other hand the non-canonical Wnt pathway works independent of ß-
catenin. Its other branch  regulates intracellular Ca2+ signaling, (Fig. 2.1 b) 
(Eisenmann, 2005). 
One of the core issues plaguing developmental biologists currently is the 
understanding of how cells and groups of cells become organized into higher order 
structures (Saburi, 2005).One form of higher organization that is currently under 





































Figure 2.1. The two Wnt pathways. (a) canonical pathway (figure 
adopted from www.wormbook.org/chapters/www_wntsignaling/ 





Planar cell polarity is the coordinated organization of cells within the plane of a single 
layered sheet of cells i.e., the organization of groups of cells in the plane of the 
epithelium, such that they all orient to similar and apparently remote co-ordinates.  
 
2.3 PLANAR CELL POLARITY (PCP) 
 
The non-canonical Wnt signaling pathway is responsible for planar cell 
polarity. In case of higher organisms, like mammals, a striking feature of the skin is 
its global polarity, which is mostly obvious from the uniform, anterior-posterior 
orientation of hair follicles. The acquisition of polarity by migrating cells in skin 
epithelia is also likely to be essential for directional cell movements that occur, for 
instance, during the healing of skin wounds, and within hair follicles during periods of 
hair growth. The mechanisms that coordinate the polarity of millions of cells over the 
body surface, ensuring that each one is oriented correctly, and those that regulate 
directional cell migration in the skin are not fully understood. Clues to possible 
underlying mechanisms are provided by recent advances in the study of planar cell 
polarity in the cuticle and photoreceptors in the eye of Drosophila melanogester, 
mammalian inner ear, and during convergent extension movements in vertebrate 
gastrulation and neural tube closure. PCP in these biological systems is regulated by 
signaling through a pathway involving the Frizzled and Disheveled proteins (McNeill, 
2002). 
 
2.3.1 Biological significance 
Mutations in the mammalian homologs of several Wnt genes acting in PCP  
cause defects in neural tube closure and loss of planar polarity of sensory hair cells in 
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the inner ear. According to Strutt (2005) the genes in this pathway can be 
phenotypically classified as: 
a) Upstream factors, including non-classical atypical cadherins like Fat, 
Daschous and Flamingo, are found to act upstream of the Frizzled receptor. 
b) Core factors, including proteins like Frizzled and Disheveled 
c) Downstream effectors, like the p21 GTPase RhoA and its putative effector 
Rho associated kinase.  
In vertebrates the PCP pathway is directed by non-canonical WNT proteins, in 
particular WNT5A and WNT11, and the interaction of DVL with RhoA through the 
novel formin homology adaptor protein Daam1. Depletion of Daam1 blocks 
gastrulation in vertebrate embryos, identifying it as an essential component of the 
WNT-PCP pathway. 
 
2.4 FAT 1  
The answer to the question of how the cells in an epithelium align themselves 
to the other cells in the tissue lies in the understanding of the interaction of upstream 
factor Fat with another cadherin Daschous and a nuclear co-repressor Atrophin 
present in the cytoplasm (Saburi, 2005). Fat1 (ft) is a non-classical cadherin type of 
molecule, often known as an atypical cadherin. It is the first tumor suppressor gene to 
be identified in Drosophila (Mahoney, 1991). Cadherins are found in several 
invertebrate and vertebrate species and form the largest group in mammals and are 
implicated in signaling, differentiation of specific cells, homophillic and heterophillic 
adhesion (Sano, 1993). 
Cadherins are type-1 transmembrane protein. They are one of the four types of 
cell adhesion molecules and play an important role in cell adhesion by maintaining 
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cells together in tissue. They use Ca2+ ion for cell signaling from where they derive 
their name. The important members of the cadherin super family consist of classical 
cadherins, protocadherin, desmogleins and desmocollins. All cadherins posses an 
extracellular domain for the binding of Ca2+ ion and this is characterized by identical 
repetitive domains. Individual cadherin family is further divided depending on the 
tissue on which they act upon by a single letter prefix. For example E-cadherin is 
found acting in the epithelial tissue, while an N-cadherin acts on neurons. It has been 
found that the cadherins separate themselves from one another during development 
(Nollet, 2000). 
 
2.4.1 Architecture of Fat1 
 
Fat1 contains 34 extracellular repetitive domains, the largest among cadherins. 
Apart from this, it contains five epidermal growth factor (EGF) repeats followed by 
two lamin A-G binding domain, a putative transmembrane region and an intracellular 
domain having distant identity to the least studied catenin binding tails of cadherins 
(Fig. 2.2). The cytoplasmic domain of all Fat-like members is found to be conserved 
from flies to vertebrates (Fanto, 2004). 
The function of vertebrate Fat, known as Fat1, has largely been studied only in 
Drosophila melanogester. It is said to play an important role in imaginal disc 
formation, regulation of disc growth (Clark, 1995), establishment of PCP in the eye, 
wing and abdomen by the sub-cellular polarization of core planar polarity proteins 
during the pupal stage (Adler, 1998) and in the proximal patterning of some 
appendages (Bryant, 1988). It has been alternatively hypothesized that both Fat and 
Daschous may partially or wholly act as a receptor and a ligand where the 

























Figure 2.2. Domain architecture of Fat, a tumor Suppressor 
cadherin (a) comparison of Fat and other cadherins and (figure adapted 
from Tepass U ,Current Opinions in Cell Biology) (b) different 







Atrophin, (Atro) also known as Grunge, belongs to the class of nuclear 
receptors. Nuclear receptors (NRs) comprise one of the largest known families of 
eukaryotic transcription factors (Mangelsdorf, 1995). The majority of identified NRs 
are ‘orphan’ receptors (without known ligands). Many of these orphan NRs are 
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conserved between vertebrates and flies (King-Jones, 2005), which makes the fly an 
ideal model system to study their properties. A major function of NRs is 
transcriptional repression. 
These proteins are characterized by several stretches of conserved domains, namely 
SANT (SWI3/ADA2/N-CoR/TFIII-B) domain, and an Arg-Glu repeat region (RERE) 
(Tsai et al., 1999). Mutations in Atro have been shown to cause a variety of patterning 
defects in Drosophila (Erkner, 2002).  
 
2.5.1 Architecture of Atrophin 1 
 
Vertebrate genomes usually harbor two Atrophin genes, Atrophin-1 and 
Atrophin-2. The putative Atrophin protein is 1966 amino acids long in Drosophila, 
while the mouse protein is much smaller. Sequence comparison shows the presence of 
the following four distinct domains in Atrophin 1 and related proteins, Fig. 2.3(Shen, 
2007). 
a) The extreme N terminus (a.a. 1-200) amino acids is not present in Atrophin1 
but only in Atro of Drosophilla, and Atrophin2 and bears sequence identity to 
MTA-2 related protein. This region is characterized by glutamic acid at the 
12th and 14th amino acid position which helps in the nuclear localization of the 
protein. 
b) N terminus spanning the next 500 amino acids is essentially conserved in 
Atrophin1 and Atrophin2. 
c) Middle region, spanning the next 400 amino acids, is proline rich. 
d) C-terminus, nearly one third of the mammalian Atrophin1 protein, bears 33% 
identity to the Drosophila Atrophin protein and 27% to Atrophin 2. This 
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region is rich in charged amino acids; especially Arg-Glu (RE) repeats (RE) 
and is highly conserved among all atrophin1 proteins. 
Atrophin1 containing poly glutamine repeats have been attributed to cause 
dentatorubral-pallidoluysian atrophy resulting in neuronal apoptosis. The activity of 
Atro also regulates the output of other signaling cascades during development. 
Several defects, such as polarity, neurogenic and cleft notum phenotypes, observed in 
Atro mutants, are reminiscent of characteristic phenotypes associated with disruption 
of the Wnt, Notch, Dpp, and JNK signaling pathways. Since the activation of these 
signaling pathways often leads to eventual transcriptional changes within the nucleus, 
it is conceivable that some downstream transcription factors in these signaling 




Figure 2.3. Domain architecture of Atrophin1 like protein. red: 
Atrophin1 like domain; pink: Zinc finger domain; yellow, light green: 
Myb or DNA binding domain and SANT domain; orange: ELM2 
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2.6 ROLE OF FAT AND ATROPHIN1 IN PCP 
 
The exact roles played by both the two proteins, and how they contribute 
together in controlling planar cell polarity in vertebrates is still under investigation.  
 
Figure 2.4. Depicts the planar polarity in the compound eye of the 
Drosophila. (a) the compound eye of the Drosophila (b) ommatidia on 
either side of the equatorial plane of the eye are mirror images (c and 




Fat and Atrophin in Drosophila melanogester were found to control the 
expression of four jointed (fj), which in turn controls polarity and also the directional 
alignment of the photoreceptors of the eye R3 cells, (Fig. 2.4) (Fanto, 2003). 
The Atro protein is found shuttling to the cytoplasm while it is mostly 
localized inside the nucleus. On the other hand, Fat1 is expressed in high level in the 
fetal epithelia at the cell membrane. A yeast two hybrid screen revealed that the last 
160 a.a. of Fat binds to the C-terminal domain of Drosophila Atrophin, (Fig. 2.5) 
(Fanto, 2003). This was reconfirmed by GST-pull down assay. With this conclusive 
evidence of the two proteins interacting both genetically and in vivo in Drosophila, 
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there was a need to understand how the two proteins actually interacted in bringing 
about planar cell polarity.  
 






Figure 2.5. Fat and Atrophin interaction (a) overall predicted 
interaction of Fat and Atrophin (figure adapted from Saburi et al. 
Current Opinion Cell Biology 2005) and (b) domains involved in the 
interaction (Figure adapted from Fanto et al. Development 2003). 
 
 
It was found by (Fanto, 2003) that the phenotypic expression of the mutants of 
the individual proteins caused a pattering defect similar to that with the absence of 
both .This kind of patterning defect was found in the development of R3 
photoreceptor in the eye, closure of the last thoracic segment in the abdomen of the 
Drosophila and many other tissues, suggestive that Fat and Atrophin may function 
together during development. 
 
 
2.6.1 Domains of interest 
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During the Yeast two hybrid experiment carried out by  (Fanto,2003),the bait 
corresponding to the last 160 amino acids from the C-terminal of Fat was found to 
binding to the C- terminal of Atrophin, while the portion of the C-terminal close to the 
transmembrane region was not found binding. Substantive proof of this was provided 
by (Blair, 2006) that the C-terminal of Fat was the domain that was required for both 
growth and planar cell polarity in Drosophila. Therefore the gene fragment 
corresponding to the C-terminal 160 a.a. of Fat1 was obtained by RT-PCR from the 
mRNA of Mus musculus (mouse). Mouse Fat1 shows high homology to human FAT 
and less homology to Drosophila Fat. The C-terminal of Atrophin (Xu,2002) was 
found to have highest similarity among species and was found binding to the C-
terminal of Fat (Fanto,2003).The Mus musculus putative Atrophin protein is 1175 a.a. 
long, shorter than the Drosophila counterpart at its N-terminus and bears highest 
similarity to the C-terminus of the human Atrophin1(Fig.2.6). Around 196 amino 
acids from the C-terminus of Atrophin1 from Mus musculus C-terminal was used for 
structure determination studies.  
 
 
Figure 2.6. Comparison between the Drosophila Atrophin and the 
  two Atrophins in humans. (Figure adapted from Zhang et al. Cell 
2002) 
 
2.7 DNA METHYLATION 
 
 The second project that I have undertaken is on gene regulation. Epigenetics 
can be defined as the change in gene expression that are controlled by factors external 
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to a gene sequence without any change to the gene itself in a genome (Turner, 2007). 
Epigenetic code is the defining code of every eukaryotic cell consisting of specific 
epigenetic changes in each cell and is tissue and cell specific. Epigenetic changes  can 
be inherited and subsequently removed without any change in the original sequence. 
DNA methylation is one such mechanism by which epigenetic modification occurs. 
While the normal physiological function of methylation is to suppress junk DNA, 
mostly this chemical modification can also lead to repression of transcription and 
alteration of the chromatin structure.  
Methylation involves the addition of a methyl group of fifth carbon of cytosine 
(C). This modification occurs more frequently at a cytosine when it is followed by a 
guanine (known as CpG). In mammals unmethylated CpGs are mostly clustered as 
islands around the 5’ regulatory end of several genes and 60-90% of CpGs are 
methylated. In diseases like cancer, gene promoter CpG islands acquire abnormal 
hypermethylation, which results in heritable transcriptional silencing. DNA 
methylation affects the transcription of genes in two ways. First, the methylation of 
DNA may itself physically impede the binding of transcriptional proteins to the gene 
and secondly, and more likely and importantly, methylated DNA may be bound by 
proteins known as methyl-CpG-binding domain proteins (MBDs). 
 
2.7.1 Components of DNA methylation 
 
DNA methylation of the genome is catalyzed by enzymes known as DNA 
methyltransferases (DNMT). MBD proteins bind to methylated CpG’s and compact 
them. MBD proteins contain a conserved methyl-CpG binding domain (MBD) and 
they also recruit additional chromatin remodeling proteins, such as histone 
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deacetylases to modify histones, thereby forming compact and inactive chromatin, 
termed as silent chromatin.  
The MBD family of proteins represents an important class of chromosomal 
proteins and their general properties firmly tie them to transcriptional repression. Five 
mammalian MBD proteins, Mecp2 and MBD1 - MBD4, have been shown to interact 
with methylated DNA. Each of these proteins has a stretch of sixty to eighty residues 
with a high level of similarity (50-70%).  
 
2.8 METHYL BINDING DOMAIN PROTEIN 1 
 
It is thought that MBD1 binds specifically to methylated DNA in any 
sequence context and inhibits transcription, but the biochemistry of MBD1 activity is 
somewhat less certain. The protein was initially reported to be a component of the 
MeCP1 complex (Cross, 1997), although this finding has subsequently been 
questioned (Ng, 1999). MBD1 is a unique member of the MBD family of proteins, 
with five isoforms so far identified. All these isoforms are characterized by the 
presence of a conserved Methyl Binding Domain (MBD) and a transcription 
repression domain (TRD). The biochemical details of the interaction of MBD1 with 
other proteins have yet to be established, but clearly the protein does stably interact 
with several other nuclear factors, including the proteins that are involved in histone 
methylation, forming a novel repressive complex (Ichimura, 2005; Sarraf and 




2.8.1 Domain architecture of MBD1 
While the most important domain is the methyl CpG binding (MBD) domain 
at the N-terminus of the full length protein, the hallmark of the protein is the existence 
of three CXXC domains at the middle region. This region is highly cysteine rich, and 
splice variation at this region leads to the formation of the five isoforms. This domain 
contains zinc finger like motifs and is unique only to MBD1. This MBD domain and 
the Transcription Repression Domain (TRD) jointly represses the transcription of 
methylated genes  
 
even from a distance (Ng, 1999). The domain arrangement of MBD1 is given 
in (Fig. 2.7.) The MBD domain, in complex with hypermethylated DNA, has been 






Figure 2.7. Domain Architecture of MBD1. Red: MBD domain; 
blue: zinc finger like motifs. 
 
2.8.2 Biological significance of MBD1 
 
Aberrant hypermethylation at the promoter CpG region of tumor suppressor 
genes leads to the silencing of these genes and thus actively contributes to 
tumorigenesis (Fig. 2.8). Histone 3 lysine 9 (H3K9) methylation is generally achieved 
when MBD1 recruits another protein, SETDB1, together with Chromatin Assembly 
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Factor 1 (CAF1) and forms a stable complex ;thus silencing the tumor suppressor 
gene p53 is activated (Sarraf, 2004). Even though the role of MBD proteins has been 





about the function of MBD1 in this context. 
 
Figure 2.8. The mechanism of gene silencing and  tumorigenesis. 




With the knowledge about 3D structure of proteins of the Wnt signaling 
pathway and the associated proteins at its infancy, deep interest among developmental 
biologists in elucidating the details of this pathway imposes adequate thrust for the 
structural studies of these proteins. Proteomic studies in Drosophila have provided a 
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better understanding of probable interactions, but currently, the exact mechanism is 
only speculative. 
Even though there is scant knowledge about the mouse homologues of Fat and 
Atrophin, the relatively high homology with the Drosophila sequence may suggest a 
better model. The structure of the C-terminal domain of Atrophin 1, with its Arg-Glu 
repeats, will provide a basis for understanding other Atrophin1 domain containing 
proteins and their role in Dentatorubral Pallidoluysian atrophy. The structure of 
Atrophin1 - Fat1 complex will provide in-depth information about interaction of 
proteins involved in the formation of planar cell polarity. On the other hand, the 
structure of the C-terminus of Fat which is the least known of all the domains may 
help us understand its role in Wnt  Ca2+ signaling.  
 DNA hypermethylation has been implicated in silencing of several tumor 
suppressor genes. Thus, the role of MBDs in cancer has become the centre of research 
focus on MBD’s. The NMR structure of MBD1 methyl binding domain with 
hypermethylated DNA provides us the basic knowledge about the mechanism of 
interaction. While the MBD domain helps in nuclear localization of the protein, the 
zinc finger motif is known for is methylation independent localization (Jorgensen, 
2004). Furthermore, MBD1 contains a C-terminal transcription repression domain, 
which is relatively less studied. Thus structural study of MBD1 will help pave a way 
to study the contribution of all domains to transcription repression and also to the 
study of its five isoforms.  
In this project I have cloned, expressed and purified the C-terminal domains of 
both Fat 1 and Atrophin 1 for crystal structure determination. The solving of  
individual protein structure and that of their complex will be attempted. Also, I have 
cloned full length MBD1 and the structure of full length MBD1 and that with 
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methylated DNA will be carried out subsequently. These project, when completed, 
will provide a firm backbone on which functional studies can be carried out later to 


























MATERIALS AND METHODS 
 
3.1 CLONING OF C-TERMINAL FAT1 AND ATROPHIN1  
3.1.1 Cloning of C-terminal Fat1  
 The cDNA encoding the C-terminus of Fat1 (4427-4587) a.a. was cloned 
from the Mus musculus (mouse) mRNA, into the pGem-T easy (Promega) vector. 
Reverse transcriptase PCR was used with the upstream primer having BamH1 and 
downstream primer having Hind3 restriction sites. A 1 µg reaction with DTT (0.1 M, 
Invitrogen) 1 µl, 5X RT Buffer (Invitrogen) 2µl, dNTP (10 mM, Roche) 0.5 µl, 
RNAsin (Promega) 0.5 µl, Oligo DT (50 µg/µl, Promega) 0.5 µl, RNA (1.6 µg / µl) 
0.6 µl, Superscript3 RT (Invitrogen) 1 µl, nuclease-free reaction water 3.9 µl was used 
to carry out the RT 40 cycles. 
 The RT reaction was followed by a normal PCR reaction to amplify the gene 
of interest. A 50 µl PCR reaction mix with MgCl2 (Promega) 3 µl, Mg free 10X PCR 
buffer (Promega) 5 µl, dNTP (10 mM, Roche) 1.5 µl, Primer (10 µM) 2 µl each, 
cDNA (2ng) 1 µl, dH2O 34.5 µl, Taq Polymerase (Promega) 1 µl was used. The PCR 
reaction was carried out for 35 cycles. The initial denaturation was at 94 °C for 6 min, 
followed by the cycles with denaturation at 94 °C, annealing at 52 °C and extension at 
72 °C, all for a duration of 30 sec each. The final extension step was at 72 °C for 10 
min. The primers that were used for Fat1 PCR are given in Table 3.1. The PCR 
product was gel extracted from a 1% agarose gel using Qiagen gel extraction kit 
following the manufacturer’s protocol. The PCR product was ligated into the pGem T-
Easy vector (Promega) following the manufacturer’s protocol. The pGem T-Easy is a 
3 kb linear vector with an overhanging T base at both ends. The T overhangs 
complement with the A bases present at the ends of the insert when PCRed using the 
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Taq DNA polymerase and the insert was ligated with the composition: pGem T-Easy 
vector (50 ng/µl) 1 µl, PCR product (approximately 50 ng/µl) 2 µl, 2X ligation buffer 
5µl, distilled water 1 µl, T4 ligase (Promega) 1 µl. 
 
3.1.2 Cloning of C-terminal Atrophin1 
 
The cDNA that encodes the C-terminal domain of Atrophin1 (979-1175) a.a. 
was amplified from Mus musculus (mouse) mRNA as explained in the previous 
section. An upstream primer having Sac1 and a downstream primer having Hind3 
restriction sites, respectively were used for PCR amplification. Initial denaturation at 
94 °C for 4 min was followed by 30 cycles of denaturation at 94 °C, annealing at 60 
°C and extension at 72 °C, all for a duration of 30 sec each. The final extension step 
was carried out at 72 °C for 10 min. The primers used for cloning the C-terminal 
Atrophin 1 for different vectors are given in Table 3.1. The PCR product was gel 
extracted from 1% agarose gel using the Qiagen gel extraction kit and the gene was 
cloned into the pGem-T Easy vector. 
Table3.1. The primers used for PCR for Fat1 cloning into the pQE30 
and pET-Duet vectors and for Atrophin 1, with respective vectors, are 
given. The included restriction site is given in parentheses and 
underlined in the sequences 
 
   Fat1 
Forward primer (BamH1): 5´ - TTCTT GGATCC TAT GAC ATT GAA AGT GAC 
TT - 3´ 
Reverse primer (Hind3): 5´ - TTCTT AAGCTT TCA CAC TTC CGT ATG CTG 




Forward primer (Sac1): 5´ - TTCTT GAGCTC AGC CTG GGG CCC CTG GAA C 
 - 3´ 
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Reverse primer (Hind3): 5´ - TTCTT AAGCTT TCA CAG CGG CTT GTC ACT 
CTCC - 3´ 
 
pGex-4T1 primers 
Forward primer (Ecor1):5´CTT GAATTC AGC CTG GGG CCC CTG GAA CG-3´ 




Forward primer (Ecor1):5´-CTT GAATTC AGC CTG GGG CCC CTG GAA CG-3´ 




Forward primer (Nde1): 5´-CTT CATATG AGC CTG GGG CCC CTG GAA- 3´ 
Reverse primer(Xho1): 5´-CTT CTCGAG TCA CAG CGG CTT GTC  ACT-3´ 
    
. 
 
3.1.3 Blue white colony screening 
 
 The ligation reaction of insert with the pGem T-Easy vector was carried out 
for 90 min, after which the product was transformed into DH5α competent cells 
(Invitrogen) and plated onto a Luria Bertani (LB) agar plate containing 100 µl of 
IPTG 0.1 M (Invitrogen) and 20 µl (50 mg/ml) X- Gal (Bio-Rad) and incubated 
overnight at 37 °C. Next morning the plate was found to contain both blue and white 
colonies. Several white colonies were interspersed on the plate. Around ten white 
colonies were picked and replated onto a fresh LB plate. Several single colonies were 
picked from these replated plates and inoculated into 2 ml LB broth and grown 
overnight at 37 °C. The culture was spun down the next morning and plasmid 
extraction was carried out using the Plasmid Miniprep kit (Qiagen). The miniprep 
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plasmid was sequenced using the SP6 and T7 promoter primers to confirm for 
absence of any mutations. 
 
3.2 SUBCLONING OF FAT1 AND ATROPHIN1 
 
3.2.1 Touch up PCR for Fat1 and Atrophin1 
 
 After estimating the concentration of the miniprep by spectrophotometry, the 
DNA was diluted 50 fold and Touch up PCR of the template was carried out using the 
same upstream and downstream primers. A 50 µl reaction containing MgCl2 (25mM) 
3 µl, 10X Mg-free buffer 5 µl, dNTP (20 mM) 1.5 µl, primer (10 µM) 2 µl each, 
pGem T-Easy insert (2 ng) 1 µl, dH2O 34.5 µl, Taq polymerase (Promega) 1 µl. The 
PCR was carried out with an initial denaturation of 94 °C for 4 min followed by the 
Touch up cycle, which involved increase in the annealing temperature form 50 to 55 
°C for Fat1 and between 50 and 63 °C for Atrophin1 by 1 ºC per cycle followed by 25 
cycles at the final annealing temperature for extension. The final extension step was 
72 ºC for 5 min. The PCR product was gel purified using a 1% agarose gel followed 
by extraction using the Qiagen gel extraction kit. Once the sequence was verified, the 
gene inserts were sub-cloned into corresponding vectors. 
 
3.2.2 Double digestion, phenol-chloroform purification and ligation of Fat1 
 
  The insert obtained after PCR of Fat1 from the pGem T-Easy construct was 
digested by incubating 5 µl of purified PCR DNA product (about 50 ng/µl) with 20 U 
of BamH1 (NEB) in a total reaction volume of 20 µl. Two microlitres of the pQE-30 
vector (Qiagen) and the pET-Duet vector (Novagen) (50 ng/µl) were digested in 
separate tubes with 20 U of the same enzyme in a total reaction volume of 10 µl. 
Concentrated 10X Buffer 2 (NEB) was added accordingly. Both tubes were incubated 
in a 37 °C water bath for one hour. Subsequent digestion with a second restriction 
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enzyme was carried out by adding of 20 U of Hind3 and 10x Buffer2 (NEB) into each 
of the tubes and the total reaction volumes were adjusted to 20 and 40 µl for the 
plasmid vectors and insert, respectively. The tubes were incubated at 37 °C in a water 
bath for additional 2 hours. Following the incubation, the plasmid and the DNA insert 
digestion mixtures were extracted with 20 µl and 40 µl of phenol-chloroform-isoamyl 
alcohol solution (25:24:1 ratio), respectively. The mixtures were micro centrifuged at 
20,000g for 1 minute and the upper layer was carefully transferred into a new 
eppendof tube. DNA was precipitated by adding 1.3 and 2.6 µl of 5 M NaCl, followed 
by 53 and 106.5 µl of cold ethanol into the plasmid and DNA insert tubes, 
respectively. Both tubes were incubated on ice for 30 minutes and DNA was pelleted 
by microcentrifugation at 20,000g, 15 minutes and 4 °C. The supernatant was 
removed and pellet was washed with 500 µl of cold 70% ethanol. Tubes were 
microcentrifuged for five minutes, 20,000g, 4 °C, supernatant was removed and the 
DNA pellet was dried in a Speed-Vac. Dried DNA pellets of the plasmid and DNA 
insert were resuspended and mixed in 8.5 µl of sterilized water. DNA insert and the 
plasmid were ligated by adding 1 µl of 10x T4 DNA ligase buffer and 0.5 µl of T4 
DNA ligase enzyme (New England Biolabs). Ligation was carried out for 1 hour at 
room temperature before transformation into DH5α competent cells and plated onto 
an LB agar-Amp plate and grown overnight. Transformants were verified by miniprep 
double digestion and sequencing. The double digest mix consisted of plasmid: insert 
construct 4 µl, Buffer2 (NEB) 1 µl, BamH1 1 µl, Hind3 1 µl, water 3 µl and was 





3.2.3 Digestion, Phenol Chloroform extraction and Ligation of Atrophin1 
 
 The phenol-chloroform procedure was used to clone the Atrophin 1 gene 
into four different vectors, pQE30 (His-tag, Qiagen), pGex-4T1 (GST-tag, GE 
Healthcare), pET32a (thioredoxin and His tag, Novagen), pET-Duet (for simultaneous 
expression of two compatible proteins, solubility tag, Novagen), using appropriate 
restriction enzymes. The clones were confirmed by double digesting and sequencing. 
 
3.3 PROTEIN EXPRESSION AND PURIFICATION 
 
3.3.1 Expression of Fat1 
 
 After sequence verification the pQE30 and pET-Duet constructs were 
transformed into M15 and Bl21 (DE3) competent cells. The M15 competent cell 
contains the pREP4 plasmid which confers kanamycin resistance. Hence the 
transformants were plated onto an LB agar plate containing 100 µg ml-1 ampicillin 
and 50µg ml-1 kanamycin for selection. Constructs with the pET-Duet vector were 
transformed into BL21 cells and selected only with ampicillin. 
 Initially, a series of experiments were carried to check and optimize 
expression. Expression was tested using 50 ml cultures before it was scaled up to 
higher volumes. The first series of trials involved testing the constructs using a time 
based experiment. Here three 50 ml culture was inoculated with 5 ml of innoculum 
grown overnight. Bacteria were initially grown to the log phase at 37 °C, and induced 
with different concentrations of IPTG (0.25, 0.5 and 1 mM). The pET-Duet clones 
showed no expression, while the pQE30 construct showed protein expression but 
most of the protein formed inclusion bodies of the protein and very little soluble 
protein. 
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 Lower temperatures and IPTG concentration can increase the solubility of 
some insoluble proteins. The condition to express the Fat1 fragment as a soluble 
protein was optimized in pQE30 (M15) .The protein was expressed in four 2.8 l flasks 
with one litre culture in each. A 50 ml innoculum that was grown overnight in a 
shaker incubator was added to each flask and the cultures were grown to an OD600 of 
0.8-1.0 at 37 ºC and the temperature of the cultures was lowered to 16 °C before 
induction with 0.1 mM IPTG. The cultures were grown for 16 hours and then the cells 
were harvested by spinning them at 9000g for 20 min. 
 
3.3.2 Purification of Fat1 
 
3.3.2.1 Affinity Purification 
 
 Bacterial pellet from 1 litre culture was resuspended in 40 ml of lysis buffer 
(20 mM Tris-HCl pH7.0, 200 mM NaCl, 2 mM ß-mercapto ethanol, 5% glycerol, 1% 
Tween-20, 10 mM imidazole, 2mM PMSF) and sonicated at 30% amplitude for 2 
rounds using Sonics Vibra cell. The pulse used was 1 sec ON and 3 sec OFF. The 
lysate was then pelleted at 40,000g for 30 min. The supernatant was then applied to 4 
ml of TALON resin (Clontech) and rotated on a rocker for 1 hour for binding. The 
resin containing bound protein was then subjected to three washes containing all the 
constituents of the lysis buffer and fourth wash with additional 10 mM imidazole. The 
protein was eluted with elution buffer (20 mM Tris-HCl pH 7.0,200 mM NaCl and 
350 mM imidazole). 
 
3.3.2.1 Size exclusion chromatography 
 
 The His-tag purified Fat1 protein was further purified by size exclusion 
chromatography on a pre-equilibrated Hi-Load 16/60 Superdex-75 column (GE 
Healthcare) with buffer (20 mM Tris-HCl pH 7.0, 200 mM NaCl, 2mM PMSF) and 
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the fractions under the peak were analyzed by SDS-PAGE for purity. The most pure 
fractions were pooled together and concentrated and stored and frozen to -80° using 
liquid nitrogen for long term storage. 
 
3.3.3 Dynamic Light Scattering 
 
 Dynamic light scattering (DYNA Pro) study was carried out on the 
concentrated Fat1 sample to analyze its poly-dispersity. 30µl of the protein was 
aliquoted and microcentrifuged at 20,000g for 30 min at 4 °C. 18µl of the protein was 
used for analysis. The cuvette was checked for any previously bound proteins, by 
measuring the count for distilled water. The count was maintained between 10-15 




Once the various concentrations were verified for their polydispersity and the 
polydispersity index obtained was sufficiently good(range 10%-30%) the remaining  
frozen protein was thawed and was set up for crystallization using sparse matrix 
Screen1 and Screen2 kits from Hampton at protein concentrations of 2, 3, 4.9 and 7 
mg/ml. The protein was set up using hanging drop method, at room temperature. 
 
3.4 EXPRESSION AND PURIFICATION OF ATROPHIN1 
 
3.4.1 Expression analysis of Atrophin1 cloned in pQE30 
 
Once the four clones of Atrophin 1 were verified they were then tested for 
expression. The pQE30 construct was transformed into M15 cells for expression. The 
pGEX-4T1, pET32-A and pET-Duet constructs were transformed into BL21 (DE3). 
Most of the protein expression trials followed standard protocols. When the OD600 of 
the culture was 0.5-0.6, protein expression was induced with three concentrations of 
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IPTG (0.25, 0.5 and 1.0 mM). A time course study was carried out to analyze the 
yield at 2, 3 and 4 hours after IPTG induction. 
In the first trial only the pQE 30 clones showed expression and the conditions 
were optimized for optimum expression and solubility. Unfortunately, most of the 
protein gave inclusion bodies. 
 
3.4.1.1 Affinity purification and refolding 
 
The C-terminal fragment of Atrophin 1 contains no cysteine residues. Hence it 
was decided to solubilize the protein that was expressed in pQE30 by refolding. The 
pellet from one litre culture (protein induction with 0.1 mM IPTG at 37 °C for 4 
hours) was sonicated using lysis buffer containing 20 mM Tris-HCl, pH 8, 150 mM 
NaCl, 2 mM PMSF). The insoluble protein was pelleted down at 40,000g for 30 min. 
The pellet was treated with 40 ml of denaturation buffer (100 mM sodium dihydrogen 
phosphate, pH 8.0, 10 mM Tris-HCl, and 8 M urea) and dissolved overnight using a 
stirrer. The dissolved pellet was filtered with a syringe filter and was passed through 
an FPLC system having a Fast Flow His trap column using a step gradient. In this 
gradient the concentration of the elution buffer is increased in steps until the protein is 
eluted out. A gradient of 30-70% was used for protein elusion. The buffer used for 
elution was the denaturation buffer but pH adjusted to 4.5. The collected fractions 
were analyzed using 12.5% SDS gel and then pooled together. The concentration was 
estimated using the Bradford method. 
  
3.4.1.2 Slow dilution and reverse phase HPLC 
 
Once the concentration of the Atrophin 1 protein was determined, the protein 
was refolded in 300 ml of refolding buffer containing only 0.1mM Tris-HCl pH 8 by 
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slow dilution. The process involved drop wise dilution of the protein with constant 
stirring at 4 °C. The refolded sample was purified using reverse phase 
chromatography with a five step gradient. Buffers A (0.01% TFA in water) and B 
(80% acetonitrile + 0.01% TFA in water) were used and the protein was eluted 
between 30-55% of B. The fractions under the elusion peak were pooled and 
lyophilized. The lyophilized protein was analyzed for refolding CD analysis by 
redissoving in Tris-HCl buffer and set up for crystallization. 
 
3.4.1.3 Circular dichroism 
 
Spectra were acquired on a J-810 Spectropolarimeter (Jasco) using a quartz 
cuvette with 1 mm path length (Hellma). The spectra was averaged over three scans 
and recorded at the wavelength region from 190 to 280 nm with 0.1 nm resolutions 
using a scan speed of 50 nm/min and a response time of 8 seconds. 
 




Initial time based experiments for pET32a: Atrophin 1 failed to show any 
expression in different cell lines. Finally, the clone did show some expression, after 
several retrials, in Bl21 (DE3). The cells were grown to an OD600 of 0.6 at 37 ºC and 
the temperature was lowered to 16 °C. Protein expression was induced with 0.1mM 
IPTG and grown for 16-18 hours. The protein was expressed as a His-tag protein 






3.4.2.2 Affinity purification 
 
Cells were pelleted and the pellet was resuspended in 60 ml lysis buffer (10 
mM Tris-HCl, pH 8, 100 mM NaCl, 2 mM ßme, 1% Tween20, 2 mM PMSF) and 
lysed using a French press (Fisher Scientific) at a cell pressure of 14000 psi for three 
rounds to completely lyse the cells. The lysate was spun down at 40,000g for 30 min 
and the supernatant was applied to 4 ml of TALON resin(charged with Cd2+) for 
protein binding for one hour followed by four washes with lysis buffer containing 20 
mM imidazole. The protein was eluted with buffer containing 20 mM Tris-HCl, pH 8, 
100 mM NaCl and 250 mM imidazole. 
 
3.4.2.3 Size exclusion chromatography 
 
Further purification of the protein was carried out using size exclusion 
chromatography on a pre-equilibrated Hi-Load 16/60 Superdex-75 column (GE 
Healthcare) with buffer 20 mM Tris-HCl, pH 8, 100 mM NaCl, 2 mM PMSF) and the 
fractions under the peak were first analyzed on SDS-PAGE for purity and the pure 
fractions were pooled together and concentrated to 1 mg/ml. 
 
3.4.3 Thioredoxin tag cleavage 
 
Trials to optimize the cleavage of the 18 kDa thioredoxin-tag were carried out 
using both thrombin (Amersham Biosciences) and enterokinase (Roche). A time based 
experiment spanning 18 hours at 4 °C for enterokinase and thrombin was used to 
determine optimal cleavage. The buffer used was the same as FPLC buffer. The 




3.4.4 Dynamic Light Scattering 
 
The thioredoxin tagged protein was analyzed for its poly-dispersity using 
dynamic light scattering (DYNA Pro). 
 
3.4.5 Crystallization set up 
 
The proteins that were obtained after refolding from the pQE30 construct and 
pET32a were set up for crystallization using Screen 1 and Screen 2 sparse matrix 
screens (Hampton). The proteins were setup at room temperature using hanging drop 
technique. The refolded protein concentration was around 3 mg/ml and that with the 
Thioredoxin-tag was 2.5 mg/ml. 
 
3.5 CLONING AND EXPRESSION OF MBD1 
 
3.5.1 Cloning of MBD1 
 
The cDNA of full length of MBD1 coding sequence (46-652) a.a. from the 
human lymphoma cell line was first cloned into the pET14B vector between the 
restriction sites Nde1 and Xho1. Subsequently, the gene was cloned into pET32a for 
bacterial expression and pFastBac HTB vector for baculovirus expression. The 
primers that were used are given in Table 3.2.   
 
Table 3.2. Primers for pET14b, pET32a and pFas Bac Htb of MBD1 
 
pET14b Primers 
Forward primer (Nde1): 5’ – CTA TTCATA TGC TTC CTG TGG CCT CCA TG-3’ 





Forward Primer (EcoR1):5’-CTT GAATTC ATG GCT GAG GAC TGG CTG-3’ 
Reverse Primer (Not1):5’-CTT GCGGCCGC CTA CTG CTT TCT AGC TCC-3’ 
 
pFas BAC Ht b Primers 
Forward Primer (EcoR1):5’-CTT GAATTC AA ATG GCT GAG GAC TGG CTG-3’ 
Reverse Primer (Not1) :5’-CTT GCGGCCGC CTA CTG CTT TCT AGC TCC-3’ 
 
The pET14b construct was transformed into DH5α cells and plated onto an LB-
Ampicillin plate. The transformants were screened by double digestion and 
sequencing to verify for the absence of mutation. 
 
3.5.2 Expression of MBD1 
 
Successful bacterial clones were transformed into BL21 (DE3) and protein 
expression was tested. The constructs failed to show any expression under different 
conditions of IPTG concentration and temperature. Full length MBD1 was cloned into 
the pET32 vector containing both His-tag and thioredoxin-tag between the EcoR1 and 
Not1 restriction sites for better solubility. However, pET32a:MBD1 failed to show 
expression in BL21 (DE3) and BL21 (pLysS). Even the RP codon plus strain as well 
as Rosetta Gami cells were used for expressing the pET32a clones without any 
success. Currently, MBD1 is being cloned into the baculovirus expression vector 








RESULTS AND DISCUSSION 
 
In order to determine the crystal structure of a protein by X-ray 
crystallography, the protein must first satisfy certain important criteria. It must be 
soluble, homogenous, and available in sufficient amount and high purity (95-100%). 
It should not aggregate at high concentrations, as a randomly aggregated protein 
hampers crystal formation. However, it is hard to predict the concentration at which 
crystals will be formed as it is entirely protein dependent. In this chapter, the 
experimental results of Fat1, Atrophin1 and MBD1 are presented. 
 
4.1 CLONING OF FAT1 AND ATROPHIN1 
 
  The cloning of both Fat1 and Atrophin1 into the pGem-T Easy was carried out 
using a standard protocol. The Fat1 cDNA of our project contains 480 bp (160 a.a.) 
while that of Atrophin1 is 588 bp (196 a.a.). Both fragments produced a distinct band 
in 1% agarose gel. The two fragments were cloned into the pGem T-Easy vector, as it 
would facilitate long term storage of genes; serve as a template for sequence 
verification and as a template for subcloning into other expression vectors. 
The pGem T-Easy construct of Fat1 was used for subcloning into pQE30 and 
pET-Duet using touch up PCR. Touch up PCR, a modification of the normal PCR 
wherein during initial few cycles the annealing temperature is increased by 1 °C per 
cycle over a pre-set range after which the amplification proceeds at the final annealing 
temperature for 25 cycles (Fig. 4.1). The regular procedure of double digestion, 
followed by gel extraction, yielded very low and undetectable amount of DNA on 1% 
agarose gel for ligation. The phenol chloroform method was thus used for extraction 
of the double digested product, followed by ligation. This method avoided the need 
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for gel extraction after double digestion, and suffient number (at least 10 in number) 
of clones was obtained upon transformation. The colonies were verified using double 
digestion, using the same set of restriction enzymes (Fig. 4.2). Successfully digested 
colonies were sequence verified. 
After initial reverse transcription and cloning into pGem T-Easy (Fig. 4.3), 
Atrophin1 was sub-cloned into pET-Duet (Fig. 4.4a), pGgex-4T1 (Fig. 4.4b), pET32a 
(Fig. 4.4c) and pQE30 (Fig. 4.4d). Double digestion verification of the different 
constructs was performed and reconfirmed by sequencing of positive clones. The 
three genes were blasted against the NCBI database and were found to be mutation 
free. 
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Figure 4.1. Subcloning of Fat1. (a) PCR from Mus musculus 
cDNA. Lanes are: M – marker, 1 and 2 - PCR product (b)  touch  up 
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Figure 4.2. Verification of Fat1 clones using Double Digest (a) 
double digest of pQE30 clones. Lanes are: M-marker, 1 to 3 
transformants, 1 showing clone at 500Kb (b) double digest of pET-
Duet MCS1 Clone. Lanes are: M-Marker, 1-2 transformants, 1&2 
showing clones at 500Kb 
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Figure 4.3. Subcloning of Atrophin1 using Touch up PCR. Lanes 
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Figure 4.4. Double digest verification of Atrophin 1 clones in 
different Vectors (a) pET-Duet. Lanes are: M - Marker Lane,1 to 5 -
transformants,1 and 4 showing the clone (b) pGEX4T1.Lanes  are: M-
marker,1 to 6 -  transformants,2,5&6 showing the clones (c) pET-
32A.Lanes are: M-marker ,1 to 3 - transformants, 3 showing the clone 





4.2 EXPRESSION OF FAT1 AND ATROPHIN1 
 
4.2.1 Expression of Fat1 
 
 Initially, a small scale expression test with 50 ml LB was carried out in E. coli 
BL21 (DE3) and BL21 pLyss for pET-Duet constructs and E. coli M15 cells for 
pQE30 constructs, respectively. The cell suspension was analyzed on an hourly basis 
and finally sonicated to check for solubility. No visible expression was observed in 
the pET-Duet clone (Fig. 4.5a) in both the cell lines, while the pQE30 clones showed 
expression when analyzed using a 12.5% SDS gel (Fig. 4.5b). In a large scale, Fat1 
was expressed in 4 L culture, initially grown at 37 °C until induction, and then 
continued at 16 °C for 16 hours. The expected size of Fat1 is 19 kDa but it always 
showed up at 30 kDa. It was suspected that the large number of negatively charged 
residues might be contributing to the size discrepancy but that was not the case on an 
SDS gel where all charge bias is annulled. A series of experiments involving high 
concentrations of denaturing agents like 8 M urea and reducing agents like 100 mM 
DTT were used to check for the existence of a dimer. The protein always produced a 
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Figure 4.5. Expression check of Fat1. (a) expression in pET-Duet. 
Lanes are: 1 –uninduced, M –LMW marker(kDa), 2 to 4 - after 2 hour 
induction with 0.25, 0.5 and 1 mM IPTG, 5 to 7 - after 3 hour, 8 to 10 - 
after 4 hours. (b) expression in pQE30. Lanes are: M –LMW 
marker(kDa), 1 to 4 before induction from 1 to 4 hours, 5 to 9 - after 
induction from 1 to 5 hours. . 
 
 
4.2.2 Expression of Atrophin1 
 
The C-terminal domain of Atrophin1 was expressed in E. coli BL21 for the 
pGEX-4T1, pET 32a and pET-Duet constructs and in E. coli M15 cells for the pQE30 
constructs, Fig. 4.6. Initially, small scale 50 ml culture was used for checking 
expression and solubility. Hourly post-induced samples were analyzed on a 12.5% 
SDS gel for expression and solubility. Only the pQE30 construct showed expression 
in the first trial while no other constructs expressed. However, the pQE30 construct 
produced inclusion bodies in the pellet upon sonication. Lowering of temperature and 
IPTG concentration also failed to solubilize the protein produced. Refolding of the 
Atrophin1 C- terminal domain was carried out. Finally, among the expression trials in 
other cell lines like BL21 pLysS, BL21 (DE3) and C43 with the pET32a construct 
showed expression in  BL21(DE3). 
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4.2.2.1 Final Expression 
 
The pET32a:Atrophin1 construct was expressed at 16 °C and an IPTG 
concentration of 0.1 mM. The protein was partially soluble, (Fig. 4.7). 
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Figure 4.6. Expression check of Atrophin1 in different Vectors (a) pGEX-
4T1 expression of Atrophin1. Lanes are: M - LMW marker (kDa),1-
uninduced,2 to 4- after 2 hours of with  0.25mM,0.5mM,1mM IPTG 
concentration, 5 to 7  after 4 hours with different IPTG concentration. (b) 
pET-Duet expression. Lanes are:1 -uninduced , M - LMW marker(kDa), 2 to 5 
- after 1,2,3,4 hours of induction with 1mM IPTG (c) pQE30 expression of 
Atrophin1.Lanes are:M - LMW marker(kDa),1- uninduced, 2-after 4hours 
with 250mM IPTG ,3-supernatant after sonication,4-pellet after sonication (d) 
pET-32 initial trial of expression. M - LMW marker(kDa),1 uninduction,2-
whole cell lysate,3 to 5-after 2,3,4hours of induction with 0.25mM IPTG. 
 
 










Figure 4.7. Final Expression of Atrophin1 in pET32a .Lanes are: 1 –
 uninduced, M - LMW marker (kDa), 2 to 4 expression at 2, 3 and 4 hrs. 
 
 
4.3 PURIFICATION OF FAT1  
 
4.3.1 Affinity purification and Size exclusion Chromatography 
 
Fat1 did not over-express very well and more than 50% of the expressed 
protein formed inclusion bodies. The yield of soluble protein was acceptable. The 
supernatant was applied to Talon (Clontech) resin for binding, followed up by four 
washes with a buffer containing 10 mM imidazole to remove non-specifically bound 
impurities. The protein was eluted with a buffer containing 350 mM imidazole. The 
protein contained a non-cleavable histidine-tag, (Fig. 4.8.).Relatively pure protein of 
lower concentration was obtained and was further purified with a Sepharose 75 size 
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exclusion column. Upon purification, protein fractions collected were analyzed using 
12.5% SDS gel, and fractions showing high purity were pooled together for 
determination of concentration (Fig. 4.9.) and further analyzed using DLS. 
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Figure 4.8. Purification of Fat1 using TALON Resin. Lanes are: M - LMW 
marker(kDa),1 and 2 - uninduced, 3 and 4 - supernatant after sonication, 5 and 
6 - pellet after sonication, 7 - flow through, 8 - wash 1, 9 – wash 2, 10 – wash 
3, 11 – wash 4, 12 –elute 1(350mM Immidazole), 13 - elute 2. 
 a                                                                      b 




Figure4.9.  FPLC profile of Fat1-(a) Purification Profile of Fat1. (b) SDS 
gel of fractions under the peak. Lanes are: M-LMW marker (kDa), 1 to10 - 




4.3.2. Dynamic light scattering (DLS)  
 
Dynamic light scattering is an effective biophysical technique that helps in 
measuring the size of a molecule and its polydispersity. It is based on the principle of 
light scattering, caused by the random motion of particles constituting the sample. 
When the DLS analysis of the purified protein Fat1 was carried out, the protein did 
not show much aggregation at 2 mg/ml with the SOS error value being 118 and 
polydispersity index value being 32.9% (Fig. 4.10a)  while the protein started to show 
slight aggregation at concentrations of 3 mg/ml (Fig. 4.10b) and heavy aggregation at 
higher concentrations. The red bars in the DLS profile indicative of aggregation. A 
native gel was run to verify the aggregation at 4 and 7 mg/ml as aggregated protein 
could not be verified using DLS (Fig. 4.10c). A non-aggregated protein would show a 
distinct band, while smear is an indication of aggregation. In spite of subsequent 
efforts to minimize aggregation (with the use of detergents and glycerol in the lysis 
buffer at the early stages of purification and thereby increasing electrostatic repulsion 
between protein molecules) did not help and the protein still showed aggregation in 
DLS. One possible reason for aggregation at higher concentration might be the 
presence of large number of random coils (predicted data) in Fat1, making the 
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Figure 4.10. DLS and native gel profile of Fat1. (a) 2.2 mg/ml 
concentration showing low aggregation and (b)7 mg/ml showing heavy 
aggregation (c) native gel showing aggregation. Lanes are: M1 – low 
MW marker (kDa), M2 - native gel marker, 1 - purified protein at 




4.3.3 Maldi-TOF and peptide mass finger printing 
 
The molecular weight of the Fat1 protein was verified using Quadruple Maldi 
TOF (Q-TOF).The protein showed a molecular weight of 19,232 Dalton which is 
around the expected molecular weight of the protein (Fig. 4.11a). This answered all 
doubts on the possibility of an oligomeric complex, caused by the 12.5% SDS gel.  


















Figure 4.11. Mass determination and verification of Fat1 (a) Q-TOF 








The apparent higher molecular weight may be attributed to the high negative 
charge of the protein, though this effect is generally nullified by sodium dodecyl 
sulphate. The identity of the protein was also verified by peptide mass finger printing 
as Fat1 from Mus musculus (Fig. 4.11b). This method involves extraction of the 
protein directly from the band on the SDS gel, subjecting it to tryptic digest, carrying 
out a Maldi-TOF analysis of the digested sample and a protein blast search against the 
NCBI  database. 
 
 
4.4 PURIFICATION OF ATROPHIN1 
 
4.4.1 Refolding of Atrophin 1 
 
4.4.1.1 Denaturation, Refolding and Purification 
 
Atrophin1 was insoluble even at lower temperature in pQE30. Hence it was 
decided that the protein should be refolded and no expression was observed in any 
other bacterial cell lines. The other added advantage was the absence of cysteine 
residues in the C terminal region, which might aid better refolding. The pellet after 
sonication was denatured, producing an adequate yield of protein for refolding (Fig. 
4.12a). The denatured protein was purified with 5 ml His Trap (Amersham) column 
(Fig. 4.12b). The affinity purified samples were pooled (Fig. 4.12c) and the protein 
was refolded using slow dilution. This method involves dilution of a concentrated 
protein in a dropwise manner in a refolding buffer and is equivalent to multiple step 
dialyses but within a short duration. The yield by this method is normally higher with 
less aggregate formation. The refolding was performed over a period of two days at 4 
°C in 300 ml of refolding buffer. The refolded protein was purified by reverse phase 
HPLC using a gradient of 30-60% buffer B. The protein eluted at 45% of buffer B 
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(Fig. 4.12d). The fractions were pooled, checked by 12.5% SDS-PAGE (Fig. 4.12e) 
and the protein was lyophilized. 
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Figure 4.12 Refolding of Atrophin1.  (a) 12.5% SDS showing the 
denaturation of the pellet with 8 M urea. Lanes are: M - marker, 1 – 1 
ml aliquot showing expression, 2 - pellet after sonication, 3 - pellet 
after denaturation with 8 M urea. (b) FPLC profile of denatured 
Atrophin1 using Fast Flow His Trap column, peak 2 at 20 ml 
containing the protein. (c)12.5% SDS showing the fractions from the 
affinity purification. M - marker, 1 to 4 - fractions under the peak, 3 
and 4 showing protein band. (d) RPHPLC of Atrophin 1 after 
refolding. Protein eluted between 30-60% concentration of Buffer B, 
The protein eluted at 45%. (e) 12.5% SDS gel showing the three 
fractions obtained after RPHPLC. M - marker, 1 to 3 - samples under 
the peak after elution using RPHPLC, 2 and 3- showing prominent 
band of refolded protein.  
 
 
4.4.1.2. Circular Dichroism 
 
The refolded protein was analyzed using Circular Dichroism. The protein was 
prepared as 50 µM sample. The obtained spectrum was not good due to the high HT 
[V]value of more than 850 and hence the protein was diluted to 25 µM. The resultant 
spectrum was more reliable showed two negative minima similar to a α-helix 
containing structure but due to the presence of large number of random coils 
interspersing the helical region of the positive peak was not significant. The results 
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revealed that the structure is a mixed one and is consistent with the result obtained 









Figure 4.13. The CD spectrum of refolded Atrophin1 at 25 µM. 
 
4.4.2 Final Expression using pET32 construct 
 
4.4.2.1 Affinity purification and size exclusion chromatography 
  
Even though the CD analysis had produced a spectrum similar to the 
bioinformatics secondary structure prediction, it was difficult to establish that the 
protein had indeed refolded properly due to absence of any soluble native protein to 
compare the structure with. Hence an attempt to express pET32a:Atrophin1 was 
pursued. The clone that successfully expressed in the initial screening experiment was 
preserved as a glycerol stock, and was used subsequently for large scale (4 l) 
expression. On lysis of the cell, using a French press, around 60% of the protein went 
into the pellet as inclusion bodies.  The protein with the thioredoxin tag was purified 
using TALON resin (Fig. 4.14). The eluted sample was further purified using size 


















the concentration was estimated to be 2 mg/ml, Fig. 4.15b.  The sample was analyzed 
by peptide mass fingerprinting. 
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Figure 4.14.  Purification of Atrophin1 using TALON Matrix. Lanes 
are: 1 - uninduced, M - LMW marker (kDa),2 - after overnight 
expression at 16°C with 0.1mM IPTG,3 -  Pellet after cell lysis,4 -  
Supernatant after cell lysis,5 -  flow Through after binding,6 -  Wash 1 
at 20mM Immidazole, 7 - Wash 2 at 20mM Immidazole,8 - Wash 3,9 - 
Elute 1 at 250mM of Immidazole 
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Figure 4.15. The FPLC profile for purification of Atrophin1- (a) 
FPLC purification profile (b) 12.5%SDS Gel showing samples under 
the peak. Lanes are: M-LMW marker (kDa),1 to 6 - sample under main 
peak,2 to 5 showing protein at 45kDa and a second band at 30KDa.  
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4.4.3 Dynamic Light Scattering and thioredoxin tag cleavage 
 
The Atrophin1 protein was of lower purity than required for crystallization. 
The fractions with single bands were pooled together and concentrated. The quality of 
concentrated protein was estimated by a DLS experiment (Fig. 4.16). The protein 
showed heavy aggregation (the red bars in the DLS are the indicators of aggregation). 
This confirmed that the protein must be further purified and prevented from 
aggregating. When expressed in pET32a, Atrophin1 was expressed as a fusion protein 
with an 18 kDa long Trx tag. This tag was required for proper folding and 
solubilization of a protein. However, the tag needed to be cleaved after purification 
and before crystallization. Enterokinase removes the Trx tag and S-tag (2 kDa) while 
thrombin removes the thioredoxin (Trx) tag only. The protein sequence of the 
pET32a:Atrophin1 construct was first verified for the presence of any additional 
enterokinase or thrombin cleavage sites, and found that there were none in the 
sequence. Thus a time based pilot scale experiment was carried out with 1 mg/ml of 
the protein, it failed to show any cleavage of the tag. No visible fusion protein, tag or 













Figure 4.16. DLS Profile of Atrophin1 with Thioredoxin Tag 
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Figure 4.17. Pilot scale Trx-tag Cleavage (after cleavage). Lanes are: 
1 to 5 - enterokinase digested protein at time periods of 1, 3, 5, 7 and 
18 hrs, respectively, M – LMW marker(kDa), 6 to 10 thrombin 
digested protein after the same time periods. 
 
 
4.4.4 Peptide mass finger printing  
 
Since the protein after gel filtration showed a second band, the protein was not 
pure enough for crystallization and for Maldi-TOF, as both these require highly pure 
protein. Hence peptide mass finger printing was the only choice to check the identity 
of the protein. The result of finger printing on the 45 kDa band showed similarity to 


















Figure 4.18 Peptide mass fingerprinting of Atrophin1 
 
4.5 CLONING METHYL BINDING DOMAIN PROTEIN 1 
 
4.5.1 Subcloning of MBD1 
 
For full length MBD1 (1815 bp), a gradient step PCR was required for initial 
extraction of the gene from the pGem T-Easy. A gradient of 50-65 °C was used. The 
amplified band (Fig. 4.19) was purified and the phenol chloroform method for sub 
cloning was adopted. Transformants were screened using double digestion (Fig. 4.20) 
and sequenced. 
 
4.5.2 MBD1 expression 
 
The MBD1 protein was expressed in pET14b. The expected protein size was 
68 kDa but there was no expression (Fig. 4.21a). It was subsequently cloned into 
pET32a.The expected protein size was 90kDa ,however, the full length protein failed 
to express at 20 and 37 °C and three concentrations of IPTG (0.25, 0.5 and 1 mM), 
Fig. 4.21b. This could be possibly due to the presence of 39 cysteine residues that 



















Figure 4.19. Gradient PCR of MBD1 from pGem T-Easy. Lanes are: 
1 to 6 different temperature gradients and lanes 1 to 4 (51-54 °C) show 
amplification. M – marker. 
 








Figure 4.20. Double digest verification of pET32a:MBD1. Lanes 
are: 1 to 5 - transformants, M – marker. Lane 2 shows a double 
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Figure 4.21. Expression check of MBD1 (a) in pET14b. Lanes are: 
M – marker (kDa), 1 and 2 - sample before induction, 3 to 5 - sample 
after 2, 3, 4 hours of induction (b) in pET32a. Lanes are: M – marker 
(kDa), 1 - sample before induction, 2 to 4 and 5 to 7 - samples after 2 
and 4  hrs of induction, respectively, at IPTG concentrations 0.25, 0.5 
















CONCLUSION AND FUTURE STUDIES 
 
5.1 CONCLUSION 
The aim of the project was to solve the crystal structure of two proteins, Fat1 
and Atrophin1, from the Wnt pathway and the protein MBD1, a member of methyl 
CpG binding proteins in order to provide 3D structure of the protein and understand 
protein protein interactions that these proteins are potentially involved into. Protein 
expression and purification of the first two proteins have been achieved and 
crystallization is underway. However, the MBD1 protein expression needs further 
experiments in higher eukaryotic systems as our attempts to express this protein in 
bacteria failed. 
Recently, it has been suggested that Fat1 may play an important role as an 
upstream effector, upstream of the Hippo signaling pathway (Pan, 2007). The Hippo 
(Hpo) pathway has a vital role to play in maintaining organ size in mammals. There 
are three possible models proposed for the interaction placing Fat and Hpo in a linear 
pathway, Fig. 5.1a). Contrasting results indicate that Fat impinges the amount of other 
signaling molecules available to Hpo (Fig. 5.1b) (Cho et al, 2006). At the same time, 
it was indicated  that perhaps some selected kinases are responsible for this pathway 
rather than the exact biochemical link connecting Fat-Dachs to the Hippo pathway. 
The MBD family of proteins has been known for gene silencing activity. 
However, their role in cancer is still not studied. While MBD4 has been well 
characterized for its role in causing cancer, the other members and their roles in 

























Figure 5.1. Proposed possible interaction of Fat (Ft) and Hippo 











Figure 5.2. Role of MBDs in tumorigenesis. (Figure adapted  





5.2 FUTURE DIRECTIONS 
 
5.2.1 Fat1 and Atrophin1 
 
The function of proteins can be better understood when their structure is 
solved. In case of Fat1 and Atrophin1, the individual structure of the C-terminal 
domains will be of enormous potential in studying the related cadherin family and 
Atrophin1 type of proteins. A knowledge of Fat1 Atrophin1 complex will help to 
provide a model as to how the non-canonical Wnt signaling is regulated during 
morphogenesis and hair follicle development. This will provide information of the 
amino acids of both proteins that are involved in complex formation. These 
interacting amino acids can then be mutated and structure of these variants will 
provide additional details leading to the development of potential treatment in related 
diseases.  
On the experimental side, an initial in vivo pull down assay of Mus musculus 
Fat1 with Atrophin1 will help ascertain their binding as in Drosophila. Once clear 
binding is established these two genes can be subcloned in baculovirus dual vector for 
co-expression. Of the two proteins, Fat1 is produced in sufficient yield and 
concentrated to about 7 mg/ml. For higher concentrations of proteins larger amount of 
cultures would be required. On the other hand, Atrophin1 only a limited amount of 
soluble protein was expressed while most of the protein formed inclusion bodies. 
 Aggregation was a problem with both proteins at higher concentrations. Even 
addition of Tween 20 or Triton –X 100 and glycerol in the initial lysis buffer or the 
usage of 50 mM lysine-glutamic acid were unsuccessful in preventing aggregation. In 
future work, the aggregation of the proteins has to be tackled before the protein could 
be set up for crystallization experiments.  
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Formation of the Fat1-Atrophin1 complex may reduce aggregation. In vitro 
binding experiments, with the help of ITC, can be carried out once the yields of the 
proteins are optimized. Also, the presence of Trx-tag may hamper complex formation 




The MBD1 full length protein with its 58 proline residues and 39 cysteine 
residues can be expressed only in a eukaryotic system for the protein to fold well as 
the reducing environment inside a bacterial cell may prevent proper folding of the 
protein. Baculovirus system, is recognized as the  system that best suits eukaryotic 
protein expression, and has the benefit of higher quality of proteins, as compared to 
yeast system. The gene first requires to be cloned in this system from the bacterial 
intermediate vector pFas Bac Htb which has been carried out. The protein expression 
requires optimization, after initial expression test a suitable yield could be obtained 
for crystallization. Apart from the individual MBD1 full length protein, a complex 
with hypermethylated DNA will give a comprehensive picture of the role of MBD1, 
especially the cysteine rich CXXC domain, in tumorigenesis. This in turn will provide 
the starting point for future drug targets aimed to interfere with MBD1 binding to the 
methylated regions of the tumor suppressor gene. The uniqueness of MBD1, as 
compared to the other members of the MBD family, will thus be fully understood 
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Table B Secondary structure Prediction of Atrophin1 (prediction from psipred) 
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Pred: 
CCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHCCCHHHHH
HEECCCCCCC 
AA: 
LGPLERERLALAAGPALRPDMSYAERLAAERQHAERVAALGNDPLARLQM
LNVTPHHHQH 
Pred: 
HHHHHHHHHHCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
CCCCCHHHHH 
AA: 
SHIHSHLHLHQQDAIHAASASVHPLIDPLASGSHLTRIPYPAGTLPNPLLPHPL
HENEVL 
Pred: 
HHHHHCCCHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
CCCCCCCCCCC 
AA: 
RHQLFAAPYRDLPASLSAPMSAAHQLQAMHAQSAELQRLALEQQQWLHAH
HPLHSVPLPA 
 Pred: 
HHHHHHHHHHCCCCCC 
AA: 
QEDYYSHLKKESDKPL. 
 
 
